Acadia Healthcare price target raised to $87 from $80 at Mizuho

Mizuho analyst Ann Hynes raised the firm’s price target on Acadia Healthcare to $87 from $80 and keeps a Neutral rating on the shares post the investor day. The company reiterated 2022 guidance, introduced initial 2023 guidance, and updated and raised longer term EBITDA goals, Hynes tells investors in a research note. The increased outlook is supported by Acadia’s investments to expand bed capacity, says the analyst. Valuation keeps her Neutral on the shares.